Literature DB >> 14985426

Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Tsuyoshi Furuya1, Hideki Hayakawa, Masanori Yamada, Kenji Yoshimi, Shin Hisahara, Masayuki Miura, Yoshikuni Mizuno, Hideki Mochizuki.   

Abstract

The present study was designed to elucidate the inflammatory and apoptotic mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in a model of Parkinson's disease. Our results showed that mutant mice lacking the caspase-11 gene were significantly more resistant to the effects of acute treatment with MPTP than their wild-type mice. Thus, the neurotoxicity of MPTP seems to be mediated by the induction of both mitochondrial dysfunction and free radical generation. Previously, we showed that overexpression of the Apaf-1 dominant-negative inhibitor inhibited the mitochondrial apoptotic cascade in chronic MPTP treatment but not in acute MPTP treatment. The present results indicate that MPTP neurotoxicity may be mediated via activation of the caspase-11 cascade and inflammatory cascade, as well as the mitochondrial apoptotic cascade.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985426      PMCID: PMC6730410          DOI: 10.1523/JNEUROSCI.3309-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  Betanodavirus B2 causes ATP depletion-induced cell death via mitochondrial targeting and complex II inhibition in vitro and in vivo.

Authors:  Yu-Chin Su; Jiann-Ruey Hong
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

Review 2.  Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease.

Authors:  Robert E Burke
Journal:  Pharmacol Ther       Date:  2007-02-27       Impact factor: 12.310

3.  A knockout of the caspase 2 gene produces increased resistance of the nigrostriatal dopaminergic pathway to MPTP-induced toxicity.

Authors:  Meenakshi Tiwari; Brian Herman; William W Morgan
Journal:  Exp Neurol       Date:  2011-03-16       Impact factor: 5.330

4.  Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology.

Authors:  Hideki Hayakawa; Rie Nakatani; Kensuke Ikenaka; Cesar Aguirre; Chi-Jing Choong; Hiroshi Tsuda; Seiichi Nagano; Masato Koike; Takeshi Ikeuchi; Masato Hasegawa; Stella M Papa; Yoshitaka Nagai; Hideki Mochizuki; Kousuke Baba
Journal:  Mov Disord       Date:  2019-10-23       Impact factor: 10.338

5.  Caspase-11 plays an essential role in methamphetamine-induced dopaminergic neuron apoptosis.

Authors:  Weiye Huang; Wei-Bing Xie; Dongfang Qiao; Pingming Qiu; Enping Huang; Bing Li; Chuanxiang Chen; Chao Liu; Qi Wang; Zhoumeng Lin; Huijun Wang
Journal:  Toxicol Sci       Date:  2015-01-27       Impact factor: 4.849

6.  Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor.

Authors:  Hua-Qing Liu; Wei-Yu Zhang; Xue-Ting Luo; Yang Ye; Xing-Zu Zhu
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

7.  Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease.

Authors:  Vivian P Chou; Novie Ko; Theodore R Holman; Amy B Manning-Boğ
Journal:  J Vis Exp       Date:  2014-01-07       Impact factor: 1.355

8.  Generation of Mitochondrial Toxin Rodent Models of Parkinson's Disease Using 6-OHDA , MPTP , and Rotenone.

Authors:  Hiroharu Maegawa; Hitoshi Niwa
Journal:  Methods Mol Biol       Date:  2021

9.  Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats.

Authors:  Zhongwang Yu; Xiaohui Xu; Zhenghua Xiang; Jianfeng Zhou; Zhaohuan Zhang; Chun Hu; Cheng He
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

Review 10.  Iron accumulation in Parkinson's disease.

Authors:  Hideki Mochizuki; Toru Yasuda
Journal:  J Neural Transm (Vienna)       Date:  2012-10-16       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.